ArticleHuman gene therapy2022

The gRNA Vector Level Determines the Outcome of Systemic AAV CRISPR Therapy for Duchenne Muscular Dystrophy.

Nalinda B Wasala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.